UCSF HELEN DILLER FAMILY COMPREHENSIVE CANCER CENTER
kmUU300MXic
kmUU300MXic
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Presentations<br />
Validating RNAseq-signatures of vorinostat (VOR) sensitivity and<br />
resistance in patients with newly diagnosed glioblastoma (GBM)<br />
treated with VOR, temozolomide and radiation therapy in Alliance<br />
N0874/ABTC-0902.<br />
Authors*: S. Keith Anderson, C. Ryan Miller, Jann Nagina Sarkaria, Kurt A. Jaeckle, Jan C. Buckner,<br />
Keith L. Ligon, Karla V. Ballman, Dennis Frederic Moore, David Schiff, Manmeet Singh Ahluwalia,<br />
Eudocia Quant Lee, Laura E. Horvath, Elizabeth Robins Gerstner, Glenn Jay Lesser, Michael Prados,<br />
Stuart A. Grossman, Caterina Giannini, Patrick Y. Wen, Evanthia Galanis<br />
Abstract #: 2029<br />
Presentation Date/Time: Saturday, June 4: 1:00 - 4:30 PM<br />
Location: Hall A, Poster Board #218<br />
Session: Central Nervous System Tumors<br />
Citation: J Clin Oncol 34, 2016 (suppl; abstr 2029)<br />
Prados Research Interests: Dr. Prados is a world-recognized Neuro-oncology expert. He led the Adult<br />
Brain Tumor Consortium for over 15 years and founded the Pacific Pediatric Neuro-Oncology Consortium<br />
(PNOC), a multi-institutional consortium of now 15 major academic centers across the United States.<br />
Currently Dr. Prados is Professor Emeritus at <strong>UCSF</strong> devoting his efforts towards pediatric Neuro-Oncology<br />
clinical and translational research. He is the co-Project Leader of a pediatric brain tumor SPORE project<br />
at <strong>UCSF</strong> and is co-Project Leader of the PNOC. His major interests are early phase clinical trials research<br />
and the translational studies that precede and inform those trials in both adults and children. He is part of<br />
the Editorial board of Neuro-Oncology, Journal of Neuro-Oncology and Journal of Clinical Oncology, and<br />
a member of the NCI/CTEP Brain Malignancies Steering Committee. In 2014 he was awarded the Victor<br />
Levin Award for lifetime clinical research excellence from the Society of Neuro-Oncology.<br />
http://cancer.ucsf.edu/people/profiles/prados_michael.3603<br />
__________________________________________________________________________<br />
Encouraging survival with Toca 511 and Toca FC compared to external<br />
lomustine control.<br />
Authors*: Timothy Francis Cloughesy, Manish K. Aghi, Clark Chen, J. Bradley Elder, Santosh Kesari,<br />
Steven N. Kalkanis, George Kaptain, Joseph C. Landolfi, Tom Mikkelsen, Jana Portnow, Joan M. Robbins,<br />
Derek Ostertag, Asha Das, Alice Chu, Michael A. Vogelbaum<br />
Abstract #: 2030<br />
Presentation Date/Time: Saturday, June 4: 1:00 - 4:30 PM<br />
Location: Hall A, Poster Board #219<br />
Poster Session: Central Nervous System Tumors<br />
Citation: J Clin Oncol 34, 2016 (suppl; abstr 2030)<br />
*<strong>UCSF</strong> authors in bold<br />
19
Change language